Literature DB >> 3171573

Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note.

H Agren1, F Niklasson.   

Abstract

In an attempt to chemically estimate cerebral energy metabolism, creatine and creatinine was measured in cerebrospinal fluid and plasma of up to 135 patients with RDC diagnoses of major depressive disorders. A strong positive age effect and a significant subdiagnostic difference were detected for both substances in CSF, but not in plasma. Primary unipolar patients had higher concentrations than either secondary unipolar or bipolar patients. Further, the two CSF measures correlated highly significantly and positively with the CSF monoamine metabolites HVA and 5-HIAA and the purine metabolites hypoxanthine and xanthine. Results indicate alterations in energy metabolism to be involved in affective disorders as well as in the regulation of monoamine and purine turnover.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171573     DOI: 10.1007/bf01243575

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  4 in total

1.  Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

Authors:  S B Heymsfield; C Arteaga; C McManus; J Smith; S Moffitt
Journal:  Am J Clin Nutr       Date:  1983-03       Impact factor: 7.045

2.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

3.  Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disorders.

Authors:  J Endicott; R L Spitzer
Journal:  Am J Psychiatry       Date:  1979-01       Impact factor: 18.112

4.  Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.

Authors:  F Niklasson; H Agren
Journal:  Biol Psychiatry       Date:  1984-08       Impact factor: 13.382

  4 in total
  16 in total

1.  Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Authors:  I-Y Choi; S-P Lee; D R Denney; S G Lynch
Journal:  Mult Scler       Date:  2010-10-04       Impact factor: 6.312

2.  Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Pharmacol Biochem Behav       Date:  2012-03-10       Impact factor: 3.533

Review 3.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

Review 4.  A potential role for creatine in drug abuse?

Authors:  Kristen E D'Anci; Patricia J Allen; Robin B Kanarek
Journal:  Mol Neurobiol       Date:  2011-03-12       Impact factor: 5.590

5.  In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.

Authors:  In-Young Choi; Phil Lee; Peter Adany; Abbey J Hughes; Scott Belliston; Douglas R Denney; Sharon G Lynch
Journal:  Mult Scler       Date:  2017-06-01       Impact factor: 6.312

6.  Phosphocreatine Levels in the Left Thalamus Decline during Wakefulness and Increase after a Nap.

Authors:  Ali Gordji-Nejad; Andreas Matusch; Shumei Li; Tina Kroll; Simone Beer; David Elmenhorst; Andreas Bauer
Journal:  J Neurosci       Date:  2018-10-03       Impact factor: 6.167

7.  Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  A hypothetical astrocyte-microglia lactate shuttle derived from a 1H NMR metabolomics analysis of cerebrospinal fluid from a cohort of South African children with tuberculous meningitis.

Authors:  Shayne Mason; A Marceline van Furth; Lodewyk J Mienie; Udo F H Engelke; Ron A Wevers; Regan Solomons; Carolus J Reinecke
Journal:  Metabolomics       Date:  2014-10-11       Impact factor: 4.290

9.  Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.

Authors:  Erik Pålsson; Carl Sellgren; Eleonore Rydén; Ruth Kizza; Aurimantas Pelanis; Henrik Zetterberg; Kaj Blennow; Mikael Landén
Journal:  J Neural Transm (Vienna)       Date:  2017-06-27       Impact factor: 3.575

10.  Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind study.

Authors:  Christiano Robles Rodrigues Alves; Carlos Alberto Abujabra Merege Filho; Fabiana Braga Benatti; Sonia Brucki; Rosa Maria R Pereira; Ana Lucia de Sá Pinto; Fernanda Rodrigues Lima; Hamilton Roschel; Bruno Gualano
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.